ARX:ASX
Aroa Biosurgery Ltd
A$0.53
arrow_downward
-1.85%(-0.010) 1D
Sep 17, 4:00:00 PM GMT+10 · AUD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
A$0.54
High
A$0.55
Low
A$0.52
Mkt. cap
183.33M
Avg. vol.
159.15K
Volume
26.70K
P/E ratio
50.86
52-wk high
A$0.80
52-wk low
A$0.50
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
Open
A$0.54
High
A$0.55
Low
A$0.52
Mkt. cap
183.33M
Avg. vol.
159.15K
Volume
26.70K
P/E ratio
50.86
52-wk high
A$0.80
52-wk low
A$0.50
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
News stories
From web sources and news partners
Kalkine Media
·
1 day ago
Top 3 ASX Penny Stocks: Could TUA, ARX and CGS Stand Out?
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd